137 filings
8-K
Alkermes Plc
8 Sep 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
Alkermes Plc
1 Aug 11
Alkermes Reports First Quarter Fiscal 2012 Financial Results
12:00am
8-K
Alkermes Plc
18 Jul 11
Alkermes Provides Outlook for Alkermes PLC and Update on Advancing Product Portfolio at Analyst and Investor Day
12:00am
8-K
Alkermes Plc
19 May 11
Departure of Directors or Certain Officers
12:00am
8-K
Alkermes Plc
18 May 11
Alkermes Reports Financial Results for Fiscal 2011 and Provides Financial Expectations for Fiscal 2012
12:00am
8-K
0qty5 j64h9b
9 May 11
Important Additional Information and Where to Find It
12:00am
8-K
5l7g2fz0tbr4ci6i44qa
9 May 11
Entry into a Material Definitive Agreement
12:00am
8-K
3i1fjkynqyeum0q
15 Apr 11
Bydureon™ Recommended for Approval In Europe
12:00am
8-K
ox6jsjc uph3z
24 Mar 11
Departure of Directors or Certain Officers
12:00am
8-K
7zo0 yqz5e93kg7z3yx4
10 Mar 11
Exenatide Once Monthly Showed Positive Results In Phase 2 Study
12:00am
8-K
a4knvms3k 5v5
3 Mar 11
DURATION-6 Top-Line Study Results Announced
12:00am
8-K
9aa8f x4nxk6v5k2
3 Feb 11
Alkermes Reports Third Quarter Fiscal 2011 Financial Results
12:00am
8-K
j5u ydyevh4oi5ey7gj
27 Jan 11
Regulation FD Disclosure
12:00am
8-K
qdshlo r7w
18 Jan 11
Alkermes Elects Wendy L. Dixon, PH.D., to Board of Directors
12:00am
8-K
av9ka5e
4 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
9pweh
20 Oct 10
Regulation FD Disclosure
12:00am
8-K
7dxop
13 Oct 10
Regulation FD Disclosure
12:00am
8-K
nkza kpp0j7ey6qmf5yo
5 Oct 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
54rtzj71gp48q3x
17 Sep 10
Alkermes Announces FDA Advisory Committee Recommends Approval of VIVITROL(R) for Opioid Dependence
12:00am
8-K
atk0 g9ki
5 Aug 10
Alkermes Reports First Quarter Fiscal 2011 Financial Results
12:00am